Conference to focus on role of biotechnology in healthcare.

Press Release Summary:



Economic Strategy for Healthcare through Bio and Information Standards will focus on the role of biotechnology in managing the escalating costs of healthcare in the U.S. It will examine the progress in the development of bioinformatics and other diagnostic tools and their potential to detect and prevent disease. The goal is to emphasize the need to develop a long-term economic strategy for implementing biotechnology into the health care system.



Original Press Release:



Conference to Examine Role of Technology in the Economics of U.S. Healthcare



NEW YORK, July 13, 2007 - The role of biotechnology in managing the escalating costs of healthcare in the United States will be the topic of an all-day conference this Sept. 25, in Gaithersburg, Md.

"Economic Strategy for Healthcare through Bio and Information Standards and Technologies" will examine the progress in the development of bioinformatics and other advanced diagnostic tools and the potential of these technologies to detect and prevent disease - in the process, bringing down the high costs associated with health care treatment.

The conference will be held at the National Institute of Standards and Technology, which is a sponsor along with the Biotechnology Council and Institute of Electrical and Electronics Engineers.

The meeting will bring government and academia together with members in the biotechnology community who are researching and developing the technologies, particularly diagnostic systems, which show the potential to advance healthcare and manage costs. The goal of "Economic Strategy for Healthcare through Bio and Information Standards," according to the sponsors, is to emphasize the need to develop a long-term economic strategy for implementing biotechnology-based devices and methodologies into America's health care system.

Participants in the conference include some of the leading thinkers and foremost authorities on the topic of healthcare. The honorary chair is Jerry Grossman, Ph.D., senior fellow and director of the Harvard/Kennedy School Healthcare Delivery Policy Program and chairman emeritus of the New England Medical Center.

ASME is a member of the Biotechnology Council and active technical publisher and meetings organizer in the bioengineering and bioprocess engineering fields. Through the resources of ASME Solutions, the Society can offer the bioengineering and pharmaceutical industry sectors streamlined knowledge-based programs designed to meet specific organizational needs and technical concerns.

Founded in 1880 as the American Society of Mechanical Engineers, ASME is a not-for-profit professional organization promoting the art, science and practice of mechanical and multidisciplinary engineering and allied sciences. ASME develops codes and standards that enhance public safety, and provides lifelong learning and technical exchange opportunities benefiting the engineering and technology community.

Contacts
John Varrasi

All Topics